http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0286516-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c275038cf36535d44a526cb28203c03d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04 |
| filingDate | 1988-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ed7c6dae25d709df001c53acbb67a68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a911cae7bdd4208ef6806b378abbc200 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b45e2c613a13f239c77a4584176df58c |
| publicationDate | 1988-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0286516-A1 |
| titleOfInvention | Amino-5,6,7,8-tetrahydro-naphtho[2,3b]furan derivatives, processes for their preparation and pharmaceutical compositions containing them |
| abstract | - R 1 représente un atome d'hydrogène ou, à condition toutefois que le radical amino soit en position 7, un radical alkyle linéaire ou ramifié refermant 1 à 4 atomes de carbone, - R 2 représente un atome d'hydrogène ou, à condition toutefois que le radical amino soit en position 6, un radical alkyle linéaire ou ramifié renfermant 1 à 4 atomes de carbone, - R 3 et R 4 identiques ou différents représentent chacun un atome d'hydrogène, un radical benzyle, un radical cyclohexylméthyle, un radical alkylène linéaire ou ramifié renfermant de 1 à 5 atomes de carbone, un radical alkyle linéaire ou ramifié renfermant de 1 à 10 atomes de carbone (éventuellement substitué par un radical hydroxy, par un radical carboxy ou par un radical alcoxy de 1 à 5 atomes de carbone, par un radical alcoxy carbonyl de 2 à 6 atomes de carbone, par un radical alkyle phényle ou par un radical alkyl thiényle-2), un radical alkyle halogéné de 1 à 5 atomes de carbone, ou forment ensemble avec l'azote auquel Ils sont attachés un radical oxo-2 pyrrolidinyl-1, - A-B représente avec l'oxygène auquel il est attaché un radical éthylènoxy, un radical éthynylénoxy, un radical oxo-2 oxy-1 éthylène ou un radical hydroxy-2 oxy-1 éthylène. Médicaments. Compounds of general formula I, in which : R 1 represents a hydrogen atom or, provided, however, that the amino radical is in position 7, a linear or branched alkyl radical containing 1 to 4 carbon atoms, R 2 represents a hydrogen atom or, provided, however, that the amino radical is in position 6, a linear or branched alkyl radical containing 1 to 4 carbon atoms, - R 3 and R 4, which are identical or different, each represent a hydrogen atom, a benzyl radical, a cyclohexylmethyl radical, a linear or branched alkylene radical containing from 1 to 5 carbon atoms, a linear or branched alkyl radical containing from 1 to 10 carbon atoms (optionally substituted by a hydroxy radical, by a carboxy radical or by an alkoxy radical of 1 to 5 carbon atoms, by an alkoxy carbonyl radical of 2 to 6 carbon atoms, by an alkyl phenyl radical or by a alkyl thienyl-2) radical, a halogenated alkyl radical of 1 to 5 carbon atoms, or form together with the nitrogen to which they are attached a 2-oxo pyrrolidinyl-1 radical, - AB represents with the oxygen to which it is attached an ethylenoxy radical, an ethynylenoxy radical, a 2-oxo-1-ethylene radical or a 2-hydroxy-1-oxyethylene radical. Medicines. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6071946-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9421608-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5684031-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0420064-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5672620-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5656661-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5639778-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2739379-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0420064-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0564358-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2689509-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0708099-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010040274-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0765877-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1053662-C http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9603396-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2725985-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5843986-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5998461-A |
| priorityDate | 1987-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 108.